How is the Whitehawk Therapeutics Inc. today?

The Whitehawk Therapeutics Inc. today is trading in the down by -3.52% at 1.92.

What is Whitehawk Therapeutics Inc. Annual Revenue?

Whitehawk Therapeutics Inc. Annual Revenue rose 6.69%, in the last year to $25.98 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Whitehawk Therapeutics Inc. Annual Net Profit?

Whitehawk Therapeutics Inc. Annual Net Profit rose 3.15% in the last year to $63.69 M. Its sector's average net profit growth for the last fiscal year was -11.04%.

What is Whitehawk Therapeutics Inc. Price to Earning Ratio?

Whitehawk Therapeutics Inc. Price to Earning Ratio is 3.28, lower than its sector PE ratio of 4.14.

What is Whitehawk Therapeutics Inc. Stock Price?

Whitehawk Therapeutics Inc. Stock Price rose 3.78% and underperformed its sector by 7.1% in the past year.

What is Whitehawk Therapeutics Inc. Quarterly Revenue?

Whitehawk Therapeutics Inc. Quarterly Revenue rose 33.48% YoY to $7.14 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Whitehawk Therapeutics Inc. Quarterly Net profit?

Whitehawk Therapeutics Inc. Quarterly Net profit rose 499.23% YoY to $73.02 M. Its sector's average net profit growth YoY for the quarter was -212.78%.

What is Whitehawk Therapeutics Inc. Debt to Equity Ratio?

Whitehawk Therapeutics Inc. Debt to Equity Ratio of 0.02 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Whitehawk Therapeutics Inc. Return on Equity(ROE)?

Whitehawk Therapeutics Inc. Return on Equity(ROE) for the last financial year was -80.79%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Whitehawk Therapeutics Inc. Mutual Fund Holding?

Whitehawk Therapeutics Inc. Mutual Fund Holding decreased by 1.05% in the last quarter to 4.76.

What is Whitehawk Therapeutics Inc. Interest Coverage Ratio?

Whitehawk Therapeutics Inc. Interest Coverage Ratio is -412.58, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Whitehawk Therapeutics Inc. Institutional Holding?

Whitehawk Therapeutics Inc. Institutional Holding increased by 6.71% in the last quarter to 36.25.

Whitehawk Therapeutics Inc. XNAS: WHWK

Whitehawk Therapeutics Inc. Live Share Price Today, Share Analysis and Chart

Name: Whitehawk Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Whitehawk Therapeutics Inc.
Rating: 2.73700
Author: Trendlyne DVM scores

about

Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engine...

1.92 -0.07 (-3.52%)

49.61% Fall from 52W High

117.0K XNAS Volume

XNAS 21 May, 2025 5:30 PM (EDT)

Not Eligible

-

Affordable Valuation

58.5 / 100

Technically Neutral

51.0 / 100

2

1Yr Price target upside is 4%

1 analysts

Whitehawk Therapeutics Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Whitehawk Therapeutics Inc. FAQ

How is Whitehawk Therapeutics Inc. today?

Whitehawk Therapeutics Inc. today is trading in the red, and is down by -3.52% at 1.92.

How has Whitehawk Therapeutics Inc. performed historically?

Whitehawk Therapeutics Inc. is currently trading down -3.52% on an intraday basis. In the past week the stock rose 14.29%. stock has been down -31.18% in the past quarter and rose 3.78% in the past year. You can view this in the overview section.